Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?
about
Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinomaTranscatheter arterial embolisation and chemoembolisation for hepatocellular carcinomaProline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activationEngineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinomaRelationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study.Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directionsThymostimulin in advanced hepatocellular carcinoma: a phase II trialA phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma.Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules.Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinomaSystemic treatment of hepatocellular carcinoma: Past, present and futureProline-rich tyrosine kinase 2 (Pyk2) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transitionPrimary liver tumors.Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells.Peritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinomaHepatocellular carcinoma--cause, treatment and metastasis.Cediranib (AZD2171) in patients with advanced hepatocellular carcinoma: a phase II North Central Cancer Treatment Group Clinical Trial.Imaging Intratumoral Nanoparticle Uptake After Combining Nanoembolization with Various Ablative Therapies in Hepatic VX2 Rabbit Tumors.Future perspectives for hepatocellular carcinoma.Hepatocellular carcinoma: therapy and prevention.Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes.Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study.Combined intra-arterial 5-fluorouracil and subcutaneous interferon-alpha therapy for highly advanced hepatocellular carcinoma.Asia-Pacific consensus guidelines on gastric cancer prevention.Is human hepatocellular carcinoma a hormone-responsive tumor?Thalidomide for treating metastatic hepatocellular carcinoma: a pilot study.Systemic therapy for advanced hepatocellular carcinoma: past, present, and future.Saudi guidelines for the diagnosis and management of hepatocellular carcinoma: technical review and practice guidelines.Advances in Local and Systemic Therapies for Hepatocellular Cancer.OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma.Skin delivery of short hairpin RNA of indoleamine 2,3 dioxygenase induces antitumor immunity against orthotopic and metastatic liver cancer.Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug.Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma.Hepatocellular carcinoma: the place of new medical therapies.Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trialFactors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients.Once-daily, low-cost, highly effective Helicobacter pylori treatment to family members of gastric cancer patients.Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.Efficacy and safety of epirubicin and etoposide combination chemotherapy in advanced hepatocellular carcinoma: a retrospective analysis.
P2860
Q21092852-4F471907-29F1-40CD-806C-6B33D13CB06FQ24247259-7C43014C-991E-4B0E-AD5E-0360312BF35CQ24309608-76E0E2DC-8D31-46E3-8329-37D7D3493C1EQ24628144-D805B666-B786-42D3-854D-20A2F0D0EE48Q25257445-6E434E63-385C-4313-A690-EEEB219E8040Q27007847-FA1E80BF-2D79-48F3-960C-8B504A2FA517Q33325625-C0AC8EE7-4A4C-45B6-9271-C56EB174804AQ33343204-73C85EE3-6E96-44CE-A706-4A5CDA2E2A1EQ33358104-C952D133-4886-4463-A51E-0BE5A9A493A2Q33742856-9FFAA644-4E69-4E54-8231-9CD0B0C32029Q33854034-3A6DD5B7-097E-4F15-997F-B05B96DF4021Q33886179-C75E8322-4830-4759-861F-0C90E6132B55Q34110964-2AF57B5C-705C-423B-A4D0-F64DBA459B80Q34233172-00E36FA5-2117-4818-BA88-6538FD2BE5B4Q34364217-9E59895A-7588-4C29-A4C0-3099B611829CQ34512068-1683369C-DB2A-4CCB-8CA8-A115B95D0955Q35078518-A24E884F-CDD5-448E-80FC-9E748B67E183Q36053235-0D96D887-BB6C-49C4-8032-E311E7BBEB25Q36063224-AD759C7D-219E-422B-97B9-E0B8DED3B0E8Q36377949-E0DA46F1-1120-4CE6-9B2F-E4C90EA8AC26Q36497118-503783C5-7679-4866-A796-B8C273726A77Q36611050-C3BAF982-1EC1-4CC9-A66D-5FFDBEB9B509Q36945072-4DCD0B0C-E48B-4D63-BC92-9E4525B6B38FQ37101686-B61036A2-838E-47C3-BBA8-F90F713181B2Q37113547-7DC2331E-BE2F-4B33-941B-154B7BAD1BA8Q37475722-35C2FE4B-A4EE-430C-B631-7117123E3D4AQ37734197-247F43A6-0538-4B8F-8C41-3F0D567183C0Q37988322-7C55BFFD-B35F-478B-BD47-14DDEE22FDAEQ38697243-3B371052-D818-4204-816F-C4FB591F2A99Q38911638-70EA5F6B-BBF8-4B03-8D59-20F9D808DF8DQ39478032-E1710AD7-2B99-4BC6-9F32-CFA8D89E7070Q39895781-9020AD29-9530-43E0-8D4B-C3525CB0D863Q40173544-219C427E-6F9E-4061-9D82-D41C3F5A8CC1Q41174836-0C9B6455-1417-4321-874F-2269FC4EAA82Q42362049-8E8CAD46-F26B-42D9-B924-69246819387DQ43924482-C908B767-E7CC-4219-A15F-FE34411B450EQ44172632-BF562D12-5B06-41AC-B8AE-B459101F41B6Q44256489-89C19EF8-FE58-4421-99CE-7161ED94E55DQ44902518-BB82CBE4-3B72-4D09-B873-0CC6D023E9A5Q46905311-436ECF4B-F5AF-4AA3-BA76-EFE5D35651EA
P2860
Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Review article: Overview of me ...... --an impossible meta-analysis?
@en
Review article: Overview of me ...... --an impossible meta-analysis?
@nl
type
label
Review article: Overview of me ...... --an impossible meta-analysis?
@en
Review article: Overview of me ...... --an impossible meta-analysis?
@nl
prefLabel
Review article: Overview of me ...... --an impossible meta-analysis?
@en
Review article: Overview of me ...... --an impossible meta-analysis?
@nl
P2093
P2860
P1476
Review article: Overview of me ...... --an impossible meta-analysis?
@en
P2093
Carbonell N
Mathurin P
P2860
P304
P356
10.1046/J.1365-2036.1998.00286.X
P407
P577
1998-02-01T00:00:00Z